These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35238930)

  • 21. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
    Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance.
    Lin YT; Huang YW; Huang HH; Yang TC; Wang FD; Fung CP
    Int J Antimicrob Agents; 2016 Nov; 48(5):485-491. PubMed ID: 27575728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    Sonnet P; Izard D; Mullié C
    Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
    Lamers RP; Cavallari JF; Burrows LL
    PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline Susceptibility and Molecular Resistance Mechanisms Among Clinical Klebsiella pneumoniae Strains Isolated During Non-Tigecycline Treatment.
    Li R; Han Y; Zhou Y; Du Z; Wu H; Wang J; Chen Y
    Microb Drug Resist; 2017 Mar; 23(2):139-146. PubMed ID: 27219271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
    Karczmarczyk M; Martins M; Quinn T; Leonard N; Fanning S
    Appl Environ Microbiol; 2011 Oct; 77(20):7113-20. PubMed ID: 21856834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Efflux Pumps AcrAB and OqxAB Contributes to Ciprofloxacin Resistance in Clinical Isolates of
    Albarri O; AlMatar M; Öcal MM; Köksal F
    Curr Protein Pept Sci; 2022; 23(5):356-368. PubMed ID: 35786184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli.
    Schumacher A; Steinke P; Bohnert JA; Akova M; Jonas D; Kern WV
    J Antimicrob Chemother; 2006 Feb; 57(2):344-8. PubMed ID: 16354746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of the ramRA locus in clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline.
    Campos CB; Aepfelbacher M; Hentschke M
    New Microbiol; 2017 Apr; 40(2):135-138. PubMed ID: 28368073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
    Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
    Laudy AE; Kulińska E; Tyski S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scalable and Chromatography-Free Synthesis of Efflux Pump Inhibitor Phenylalanine Arginine β-Naphthylamide for Its Validation in Wild-Type Bacterial Strains.
    Russo CM; Howey KG; O'Reilly MC
    ChemMedChem; 2023 Jul; 18(14):e202300128. PubMed ID: 37126222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels.
    Källman O; Motakefi A; Wretlind B; Kalin M; Olsson-Liljequist B; Giske CG
    J Antimicrob Chemother; 2008 Nov; 62(5):986-90. PubMed ID: 18647746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alliance of Efflux Pumps with β-Lactamases in Multidrug-Resistant
    Maurya N; Jangra M; Tambat R; Nandanwar H
    Microb Drug Resist; 2019 Oct; 25(8):1155-1163. PubMed ID: 31613200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of higher MICs of antibiotics and quaternary ammonium compounds for Escherichia coli isolated from bacteraemia.
    Buffet-Bataillon S; Le Jeune A; Le Gall-David S; Bonnaure-Mallet M; Jolivet-Gougeon A
    J Antimicrob Chemother; 2012 Dec; 67(12):2837-42. PubMed ID: 22904241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cell-based infection assay identifies efflux pump modulators that reduce bacterial intracellular load.
    Reens AL; Crooks AL; Su CC; Nagy TA; Reens DL; Podoll JD; Edwards ME; Yu EW; Detweiler CS
    PLoS Pathog; 2018 Jun; 14(6):e1007115. PubMed ID: 29879224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro characterization and inhibition of the interaction between ciprofloxacin and berberine against multidrug-resistant Klebsiella pneumoniae.
    Zhou XY; Ye XG; He LT; Zhang SR; Wang RL; Zhou J; He ZS
    J Antibiot (Tokyo); 2016 Oct; 69(10):741-746. PubMed ID: 26932407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii.
    Cortez-Cordova J; Kumar A
    Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of tigecycline-resistant Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
    Goodarzi R; Arabestani M; Alikhani MY; Keramat F; Asghari B
    J Infect Dev Ctries; 2021 Nov; 15(11):1677-1684. PubMed ID: 34898496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.